ESMO 2025 Highlights are Here!

The Scrip ESMO 2025 eBook brings together expert analysis, strategic implications, and actionable data from this important oncology event.

With exclusive interviews and commentary from Scrip journalists and industry leaders, this exclusive collection is your essential guide to the latest advances from the European Society for Medical Oncology congress in Berlin.

Download your free copy now and join thousands of industry professionals who rely on Scrip for daily insights.

PDF preview of the ESMO 2025 Highlights eBook from Scrip available for download.

名 *

姓 *

勤務先 *

役職 *

Business Email Address *

Country *

Business Phone

How Can We Help

fieldlabel

Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

What's inside?

Next-generation therapies: Discover how antibody-drug conjugates like Enhertu are redefining early-stage breast cancer treatment.
Competitive insights: Explore the race in triple-negative breast cancer, with Trodelvy and Datroway emerging as first-line options.
Breakthroughs in prostate, ovarian, and bladder cancer: Learn about Novartis’s Pluvicto, Merck & Co’s advances in platinum-resistant ovarian cancer, and the Padcev/Keytruda combination that’s halved the risk of death in bladder cancer trials.

Our recent awards

National Gold awarded to Scrip by ASBPE.

Eddie and Ozzie award given to Scrip for the best use of data journalism.

Award-Winning Data Journalism

Scrip receives ASBPE National Gold for delivering high-impact, data-driven pharma insights.

Excellence In Data Insights

Scrip wins Eddie Award for best use of data journalism.